Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-07 @ 11:26 AM
Study NCT ID:
NCT04082260
Status:
UNKNOWN
Last Update Posted:
2019-09-20
First Post:
2019-08-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS: Markers for Risk Stratification and Treatment Response
Sponsor:
University Hospital Muenster
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-28
First Submit QC Date:
None
Study First Post Date:
2019-09-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-18
Last Update Post Date:
2019-09-20
Last Update Post Date Type:
ACTUAL